In a report released today, Sean Lee CFA from H.C. Wainwright reiterated a Buy rating on Alphatec Holdings (ATEC), with a price target of $16.00. The company’s shares closed last Tuesday at $13.73, close to its 52-week high of $14.97.
According to TipRanks.com, CFA is a 5-star analyst with an average return of 50.2% and a 74.2% success rate. CFA covers the Healthcare sector, focusing on stocks such as ThermoGenesis Holdings, CASI Pharmaceuticals, and Gritstone Oncology.
Alphatec Holdings has an analyst consensus of Strong Buy, with a price target consensus of $16.00, which is a 22.1% upside from current levels. In a report issued on December 30, Northland Securities also maintained a Buy rating on the stock with a $17.00 price target.
See today’s analyst top recommended stocks >>
Based on Alphatec Holdings’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $41.16 million and GAAP net loss of $15.67 million. In comparison, last year the company earned revenue of $29.2 million and had a GAAP net loss of $14.57 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.